Search research articles
Contact Us
Filters
Showing results (31-40 of 169) with videos related to
Page
of 17
Sort By:
Urology
|
October 9, 2018
Surgical Management of Patients with Advanced Germ Cell Tumors Following Salvage Chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) Experience
Mariam Imnadze Miller, Andrew Feifer, Darren R Feldman, et al.
The Journal of Urology
|
August 25, 2014
Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors
Shilajit D Kundu, Darren R Feldman, Brett S Carver, et al.
Urology
|
December 29, 2011
Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer
Timothy A Masterson, Bobby Shayegan, Brett S Carver, et al.
The Journal of Urology
|
October 11, 2016
Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors
Roy Mano, Maria F Becerra, Brett S Carver, et al.
Clinical Genitourinary Cancer
|
June 25, 2011
Retrospective analysis of satraplatin in patients with metastatic urothelial cancer refractory to standard platinum-based chemotherapy
Matthew D Galsky, Sonia Seng, Luis H Camacho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2009
Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium
Matthew I Milowsky, David M Nanus, Fernando C Maluf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2015
Barriers to a Career Focus in Cancer Prevention: A Report and Initial Recommendations From the American Society of Clinical Oncology Cancer Prevention Workforce Pipeline Work Group
Carol J Fabian, Frank L Meyskens, Dean F Bajorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2003
Chemotherapy for teratoma with malignant transformation
Alessia C Donadio, Robert J Motzer, Dean F Bajorin, et al.
Cancer
|
December 1, 2015
The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents
Christopher M Tully, Andrea B Apolo, Emily C Zabor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2002
Salvage chemotherapy for patients with advanced pure seminoma
Jacqueline Vuky, Satish K Tickoo, Joel Sheinfeld, et al.
Page
of 17
Search research articles
Search
Showing results (31-40 of 169) with videos related to
Sort By:
Page
of 17
Urology
|
October 9, 2018
Surgical Management of Patients with Advanced Germ Cell Tumors Following Salvage Chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) Experience
Mariam Imnadze Miller, Andrew Feifer, Darren R Feldman, et al.
The Journal of Urology
|
August 25, 2014
Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors
Shilajit D Kundu, Darren R Feldman, Brett S Carver, et al.
Urology
|
December 29, 2011
Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer
Timothy A Masterson, Bobby Shayegan, Brett S Carver, et al.
The Journal of Urology
|
October 11, 2016
Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors
Roy Mano, Maria F Becerra, Brett S Carver, et al.
Clinical Genitourinary Cancer
|
June 25, 2011
Retrospective analysis of satraplatin in patients with metastatic urothelial cancer refractory to standard platinum-based chemotherapy
Matthew D Galsky, Sonia Seng, Luis H Camacho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2009
Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium
Matthew I Milowsky, David M Nanus, Fernando C Maluf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2015
Barriers to a Career Focus in Cancer Prevention: A Report and Initial Recommendations From the American Society of Clinical Oncology Cancer Prevention Workforce Pipeline Work Group
Carol J Fabian, Frank L Meyskens, Dean F Bajorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2003
Chemotherapy for teratoma with malignant transformation
Alessia C Donadio, Robert J Motzer, Dean F Bajorin, et al.
Cancer
|
December 1, 2015
The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents
Christopher M Tully, Andrea B Apolo, Emily C Zabor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2002
Salvage chemotherapy for patients with advanced pure seminoma
Jacqueline Vuky, Satish K Tickoo, Joel Sheinfeld, et al.
Page
of 17